Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
With BLO/BLOZF current market cap of $123,787,991 - I am going to reiterate once again that LCTC deserves to be valued at minimum equal to that of BLOZF.
For LCTC to have a comparable market cap = $50.44. That's my first target.
I am willing to at least make an argument that LCTC is further along than BLOZF in regards to completion of the first marijuana breathalyzer and from the recent report it sounds like it's finally going to be full steam ahead. We know that over $1 Million/year has been going into R&D efforts at Lifeloc - I'm not sure how that compares to the other competitors but I think it's on the low end so it may be time to ramp that up also.
The fact that your bid at $5.50 was sold into so fast lets me know we still have that one seller who is out there and has more shares to let go. It appears that he/she does not care about the earnings report or any news that comes out.
I'd really like to know who this seller is, how many shares they have left and what's their incentive for selling shares this low. If this seller can finish up, we could see some serious momentum higher.
"Lifeloc is committed to bringing the most advanced alcohol breathalyzers, alcohol monitoring devices and marijuana breathalyzers to the market."
Committed to bringing the most advanced marijuana breathalyzers to the market.
That's what I like to hear!!!
Maybe this can get some new buyers interested.
I agree that most investors and reporters have completely written off Lifeloc as a relevant competitor in regards to the marijuana breathalyzer.
If I can recall correctly, Sandia and Lifeloc have been working on this technology since 2012.
"It has been advanced to drugs of abuse through years of work under a cooperative research and development agreement between Lifeloc and Sandia."
In theory, this should put us well ahead of the competition since the SpinDX technology is already in use and proven to work in other sectors.
I believe effort has been on-going for close to 7 years now. Not sure if any of the competition can say that they have that much time put in.
So I'm in agreement that this looks very promising!
We have not seen revenue this high since 2015. I fully expect the revenue for 2019 to be $10 Million + as we start to hit our stride.
Total assets of $8.2 Million vs market cap of $13.5 Million
$.09/share vs. $.01 last year.
Revenue for 2018 grew 6% over the prior year. Our balance sheet grew even stronger, with a growth in cash of $119 thousand and a debt reduction of $40 thousand.
DWAC/FAST Eligibility:
In addition to operational investments, Lifeloc Technologies is pleased to announce that the Depository Trust Corporation (the "DTC") has approved its common stock for DWAC/FAST transfer through the Company's Transfer Agent, Corporate Stock Transfer, Inc. This newly approved stock transfer capability will enable Lifeloc's shareholders to transfer their shares of Lifeloc stock electronically after buying or selling, without the extra cost and burden associated with the processing of physical share certificates.
DWAC/FAST transfer expedites the transaction process, while also eliminating the risks associated with the loss and replacement of physical share certificates. "We are pleased to facilitate easier trading for our shareholders," said Dr. Willkomm. "Not only does becoming DWAC/FAST eligible provide our existing shareholders with new efficiencies, but we hope for more liquidity and better valuation in the open market, allowing us to continue expanding our shareholder base," he added.
Yearly earnings look good but haven't they learned that a late Friday PR or news release is the absolute worst time to put out good news.
Most companies throw out the news release late on a Friday when they want to hide things and/or have a negative headline to report.
Let's dig through this thing and see what we have!
Ideally, I would like to see some insider buys while the stock price sits around this $4.00 - $6.00 range.
If they believe in Lifeloc and it's future, this price range should have them gobbling up shares but I have yet to see any type of insider purchase.
At a market cap of anything less than $10 Million, I know I would be buying as much as I could get my hands on as long as I felt confident in Lifloc's future.
We could really use some sustained momentum. We traded above the $6.00 range but could not hold it. There still seems to be a trader who continues to knock the stock price down with a couple hundred shares each time it trades higher.
Management and the company does not give us too much to work off of, which is why it's tough to maintain any type of momentum.
Annual report is due out month end and should give us something tangible and beneficial and could provide some much needed momentum.
Recent set of investor questions sent to Dr. Wilkomm:
In regards to the new breathalyzer platform with features that customers have demanded - You were expecting to begin limited production before the end of 2018 and be running at full scale production during this current quarter. Can you please provide an update on this status? Has this been completed and ready for roll out to those customers?
The upgraded RADAR device was expected to launch in the current quarter - Can you also provide an update on this status? I have noticed that Lifeloc is hiring for a business manager for the RADAR product line. Can I conclude that the upgraded RADAR device has been completed and is ready for roll out?
Has any human testing for the marijuana breathalyzer been commenced? Can we expect any updates on the SpixDX technology and the progress being made?
I would have liked to also see some effort taken in regards to being more active on social media. This was an area that I thought was being worked on but I continue to see minimal effort and lack of investor awareness.
* I have yet to hear from the CEO in regards to these questions.
Feel free to send the same set of questions (or any additional questions) to Mr. Wilkomm if you would also like to know these answers.
It's great to see that Lifeloc continues to post new employment job listings. It would also be great to see highly educated and skilled workers take initiative and accept these positions. As far as I can see none of the new job listings have been filled yet. Let's see some highly qualified individuals apply for and get hired for these positions and get moving on these new opportunities.
SpinDx Can Identify Nearly Any Cause of Illness:
https://livepast100well.com/sandias-spindx-can-identify-nearly-any-cause-of-illness/?fbclid=IwAR2pRGMmiTWZg5zN3g5sZ8_z7bh2RnNT1aVTRX2Baw0TY4I7rO1FLlDrEwk
"SpinDx looks a bit like a DVD player inside a weather-resistant plastic case. It features a disposable disc that distributes drops of raw, unprocessed biological samples into different channels that function, according to Sandia chemist Chung-Yan Koh, like “dozens of tiny test tubes.”
This automatic distribution step is a great time saver. Chris Phaneuf, a former Sandia bioengineer explains, “instead of having to drop processed samples one by one into dozens of tiny chambers, you can load one raw sample into a single, central port that evenly distributes your sample into every channel.”
When the disc spins, the samples interact with test reagents inside the channels, and, as Phaneuf puts it, “if there’s a match, they’ll attach.” In other words, if there is a chemical interaction between the sample and reagent, a red laser causes the tip of the channel to glow, signaling an infectious agent to a software interface that displays the result.
Managed to break the $6.00 level on good volume. We haven't seen the $6's since July. We have only had one close above $6 in the last 11 months. It's important to hold above this level and not just trade right back down. It was great to see a buyer of over 3,000 shares on the bid but we still have our seller lurking who sold right into that bid at $6.00.
Let's see if we can get some follow through tomorrow because on Friday's LCTC has historically not had any shares traded. It would be great to get a close above $6.00 tomorrow and continue to see some new buyers and bids come in.
I believe that both Lifeloc and Cannabix have the potential to be buyout candidates. Most of the investors over at the BLOZF board would agree that a buyout price tag would be in the area of $300-$500 Million if not more. Keep in mind that BLOZF almost reached a market cap of $300 Million last year and it never even had produced a dollar of revenue or have a working device.
It doesn't take much for a big boy to swoop in and swallow up a company that created the first working marijuana breathalyzer. Especially one that has all the logistics and avenues in place and ready to go.
If we could envision a buyout in the $300-$500 Million range for either of these companies, we would see BLOZF trading $3-$5/share and LCTC at an astounding $120-$200/share.
And that's why for me with LCTC at these current price levels, it's the best risk/reward investment I have ever seen.
We know of at least 2 companies that are currently utilizing the SpinDX technology and are producing revenues from it:
Trak - https://trakfertility.com/
Safe H20 - http://www.safe-h2o.net/about-safe-h2o-inc
This tells me that there is no doubt that the technology works. I believe Lifeloc could be next in line to show how the technology works in a drug detection arena.
"The test chemistry has improved, boosting the reliability rate of the results from around 90 up to higher than 95 percent. With reliability that high, the system is ripe for commercialization."
Pg. 36:
https://www.sandia.gov/research/_assets/documents/SandiaResearchVol3_Iss4_FNL.pdf
A third licensee in Colorado, Lifeloc Technologies Inc., is working with Sandia to develop tests for drugs commonly abused by addicts:
Check pg. 38:
https://www.sandia.gov/research/_assets/documents/SandiaResearchVol3_Iss4_FNL.pdf
It's a great question, "What are we missing?"
I know that I have done all the research and homework that could possibly go into a company and I am absolutely convinced at some point all this patience will pay off handsomely. I just don't have the when.
Lifeloc justifiably deserves to have a market value at least that of Cannabix. I personally am looking for a return of at least 10X from the current levels. That would put us in line with our direct competitor BLOZF and put us at a valuation right near $100 Million.
What we are missing is the management and insiders lack of building any type of investor awareness or public interest. This is where BLOZF excels. They utilize timely PR's, have hired an investor relations company, and updates social media. I am ok with Lifeloc not pursuing any of these directions as long as they are progressing behind the scenes.
If LCTC can produce a working, reliable, and tested marijuana breathalyzer by the end of the year, I think we should be more than thrilled. That should get us to a market cap at least 2x that of Cannabix.
They also need to utilize social media, update investors through the use of PR's, add awareness through investor relations, etc.
I agree that it doesn't take much to get this trading in the $50's. It would have the same market cap as BLOZF, which is easily where it deserves to be. This has one of the lowest stock floats in the entire US marketplace. Can you imagine what it could do if it does wind up being the first to market with a marijuana breathalyzer?
It's tough to still see it trading near all time lows when it has so much potential.
I'd like to see us ideally take out and clear the $6.00 level. It's been over 6 months since we traded at that price.
The seller still seems to be lurking and preventing this thing from really moving and gaining any momentum.
I do believe there are enough positive catalysts in the near future to get this thing moving higher regardless of how many shares the seller has left.
"Why would you not go out and hire the most talented engineers, developers, designers, etc. to assist in the creation of this device. It's pretty much guaranteed to pay off. This should take priority over all other things."
Someone seems to be listening!:
https://www.google.com/search?q=lifeloc+job+employment&ie=UTF-8&oe=UTF-8&hl=en-us&client=safari&ibp=htl;jobs&rciv=jb#fpstate=tldetail&htidocid=gj1pohbJbb16EOM_AAAAAA%3D%3D&htivrt=jobs
Leads project development efforts for all areas within engineering.
Responsible for successful manufacturing handoff of new products and designs.
Directs and controls all new product development
Ensures that new products and custom products are fully and correctly defined, documented and tested.
Let's look at some numbers based on the Alcohol Breathalyzer and Drug Testing Equipment Market:
The worldwide market estimated at around US$ 7.3 Billion during 2017 that is likely to grow approximately US$ 13.4 Billion towards the end of 2026.
Lifeloc has revenues of approx. $8 Million/year. The worldwide market for Alcohol Breathalyzer and Drug Testing Equipment according to the latest research report is approx. $7 Billion. Lifeloc is capturing .001% of this market. To capture just 1% would lead to revenues of approx. $70 Million. I believe this is possible for Lifeloc to do in the coming years and it's great to see that they are hiring for multiple positions.
Alcohol Breathalyzer and Drug Testing Equipment Market for Lifeloc Technologies:
https://honestversion.com/alcohol-breathalyzer-and-drug-testing-equipment-market-for-lifeloc-technologies-inc-lion-laboratories-limited-andatech-pty-ltd/
"The worldwide market for alcohol breathalyzer and drug testing equipment is anticipated to increase at a 6.9% CAGR in value terms all through the calculated period 2018-2026. The worldwide market estimated at around US$ 7.3 Billion during 2017 that is likely to grow approximately US$ 13.4 Billion towards the end of 2026."
"The fuel cell based breathalyzer is likely to continue as the biggest category over the calculated period, reflecting the maximum 7.3% CAGR."
"While rising number of drunk driving instances are likely to fuel the requirement for alcohol detection equipment, it is anticipated that drugs detection category will be highly lucrative in the said period."
The major companies functional in the global market are:
Lifeloc Technologies Inc.
Lion Laboratories Limited
Andatech Pty. Ltd.
Intoximeters
Quest Products, Inc.
BACtrack
C4 Development Ltd (Alcovisor)
Drägerwerk AG & Co. KGaA
Alere (Abbott.)
Others
Looks like Lifeloc is ready to roll out the new and improved RADAR technology:
https://www.google.com/search?q=lifeloc+job+employment&ie=UTF-8&oe=UTF-8&hl=en-us&client=safari&ibp=htl;jobs&rciv=jb#fpstate=tldetail&htidocid=s30FcxkC37MpnkJrAAAAAA%3D%3D&htivrt=jobs
"Lifeloc Technologies has been upgrading this device since acquisition and now seeks an experienced sales and marketing professional to lead the market reintroduction of the R.A.D.A.R. product."
"Identify expansion opportunities for the technology and plan the introduction to market."
NEW ALCOHOL TRACKER, RADAR MAKES A HUGE IMPACT:
http://www.sober-solutions.com/new-alcohol-tracker-radar-makes-huge-impact/
"With this device rolled out, other counties and states are catching on. This system will most likely be implemented everywhere. Imagine the money we would save on keeping these offenders out of jail and on a path to sobriety. Not only will we be saving money, we will be saving lives."
The low float in LCTC is a curse and a blessing.
When the time arrives (and it will) a float lock down is most likely probable and all this waiting, praying, and wishing will pay off.
A stock with a float this small can double, triple, quadruple in a matter of minutes. If LCTC is first to the table with a working marijuana breathalyzer, OH MAN!
Let's see if we can get some follow through today. Typically we do not see any trades happen in LCTC on a Friday. Keep in mind breaking through the $5.75-$6.00 area is big and should provide some additional momentum.
I am completely satisfied with slow and steady upward momentum with most of the trades occurring on the buy side.
BLOZF has a market cap of $130 Million. I believe LCTC should have at least a similar market cap which would have it priced in the low $50's. And if we see significant cannabis breathalyzer news from LCTC in the near future, sky is the limit on this sucker.
What amazes me is that BLO/BLOZF with one simple news announcement can gain more in one day than the entire market cap of LCTC.
This is from the Cannabix PR from today:
"Thus far testing has demonstrated the ability to isolate 9-tetrahydrocannabinol ("THC") and suppress background substrates substantially."
Lifeloc has already stated and demonstrated that and more:
"The marijuana breathalyzer took a step closer to realization with the detection of delta-9-THC (the psychoactive agent) captured from a vapor sample. The ability of our technology to detect delta-9-THC down to a concentration of 5 nanograms per milliliter has been demonstrated in our laboratories."
Agreed. We are witnessing a potential multi-billion dollar opportunity with the creation of the first marijuana breathalyzer.
If I am the CEO, President, insider, director, etc. the only area of focus that I am concerned with is in the development of this device. What could possibly be more important? Police forces, municipalities, schools, etc. are lined up and ready to purchase this product. It would double, triple, quadruple the annual revenue in a matter of days.
Why would you not go out and hire the most talented engineers, developers, designers, etc. to assist in the creation of this device. It's pretty much guaranteed to pay off. This should take priority over all other things.
Incentives for Mr. Wilkomm to complete the marijuana breathalyzer by the end of the year:
Notwithstanding the foregoing performance requirements, in the event that the product known as SpinDx, including the marijuana breathalyzer which incorporates SpinDx technology, has been completed and submitted to regulatory authorities for review by or before December 31, 2019, all of the 50,000 Stock Options will vest in full, whether or not the foregoing sales and earnings requirements have been met.
BLO/BLOZF has 102,991,374 shares outstanding. At $1.30/share, that gives Cannabix a market cap of $133,888,786.
LCTC has 2,454,116 shares outstanding. At $4.18/share, that gives Lifeloc a market cap of just $10,258,204.
Cannabix is valued by the market at over 13 x that of Lifeloc. This is utterly insane.
Lifeloc deserves to be valued at least half that of Cannabix. That would equate to a stock price of $27.27.
If Lifeloc was valued equal to that of Cannabix, it would equate to a stock price of $54.55.
In my personal opinion, I believe that Lifeloc should be valued at closer to 2 x that of Cannabix which would put a stock price of $109.11
I only see two possible outcomes here - Both of which have Lifeloc trading higher than where it currently is.
Does anyone here on this message board disagree/agree with these thoughts?
I would love to hear some opinions.
Thanks!
Thanks for the info:
To clarify, if we add back the 45,500 shares that were not owned by Barry, we get a float of 226,567 shares.
According to the latest annual report, LCTC had 75 shareholders. If we divided the float equally among all 75 shareholders, each shareholder would need to own approx. 3,020 shares to lock up the entire float and at current prices it would still take less than a $ Million to secure the float in Lifeloc.
If I had the capital, I would love to bid in the high $3.00's and low $4.00's and suck up all the shares being sold down here. I believe the base for the stock should be right around $3.50. I can't imagine how it goes lower than that.
Lifeloc may or may not be the first to produce the marijuana breathalyzer but I would bet they have the most accurate/reliable one on the market when the time comes.
DragonKrys, anything more to add? Seems like you do your homework and I'd like to know if you would like to provide any additional info.
Thanks and all the best!
Lifeloc Technologies LCTC stock float:
After doing some extensive research to find out the true public stock float of Lifeloc, I have the following to report:
I believe that LCTC has a float that is approx. 180,000-190,000 shares.
In 2016 Barry Knott was the current CEO and owned 109,625 shares of LCTC.
Gurumurthi Ravishankar also owned 10,000 shares.
As these gentlemen are no longer associated with the company, their shares are not included in the total shares owned by officers/directors of the company. These numbers are included in the current total float of 362,192 shares.
In 2013, Robert H Summers owned 11,500 shares and Mark A Lary owned 50,000. These were officers/directors of Lifeloc at the time and are no longer associated with the company so their shares are also included in the current total float of 362,192.
These shares that were once held by insiders total 181,125 shares.
If the current stock float of 362,192 is subtracted from these shares, we get a total of just 181,067 shares.
No shares have ever been sold by any current insiders, officers or directors except for 3,000 shares that were once owned and sold by Ms. Kornelsen.
This leads me to believe that the current seller that continues to repeatedly come in with 1,000 share lots to sell has to be either the former CEO Barry Knott or Mark A Lary disposing of their previously held shares.
With a true float less than 200,000 shares, Lifeloc has a public stock float that is in the top 10 lowest floats of all US companies traded on all exchanges.
At the current price of $4.18, the entire public float can be bought up/locked up for approx $750,000. This is just mind blowing.
This company/stock is one of the best kept secrets in all of the land. I understand that it has been dead money for a long time but when it decides to move, we are going to see something amazing. I know it, see it, feel it and believe it.
Interesting article on the SpinDX technology and how it's being used to identify nearly any cause of illness, including viruses, bacteria, toxins or immune system markers of chemical agent exposure:
https://phys.org/news/2019-01-device-enables-mobile-viruses-bacteria.html
"SpinDx has been licensed by industry partners (Including Lifeloc) for uses as diverse as male fertility testing and water supply safety monitoring."
Taser back in 2003 had what was considered a tiny float of 2.2 million shares. Taser traded from around $4.00 to more than $82 during 2003 and continued to reach new highs surpassing $150/share. Taser currently has a market cap of around $3 Billion.
Tilray has a public float of about 17.8 million shares and IPO'ed around $17/share and hit a high of $300/share last year. Tilray currently has a market cap of around $7 Billion.
Lifeloc has a public float that would be considered miniscule by anyone's standards. It is considerably less than that of Taser and Tilray. Lifeloc has similar revenue numbers to that of Taser in 2003. I believe the marijuana breathalyzer will be comparable to that of the Taser in it's early years. Tremendous growth potential, barriers to entry are high, unique product, demand for the product is coming from all areas of the planet, etc.
If we were to ever see Lifeloc with a similar market cap to that of Taser, (assuming the shares outstanding stay the same) Lifeloc would trade at $120,000/share. This may sound absurd but a marijuana breathalyzer has similar potential to that of the Taser stun gun. Is it out of the realm of possibilities - not really. Lifeloc's float could be swallowed up quickly if news of a working and reliable marijuana breathalyzer was realized. Sky is the limit when the entire float becomes locked up and everyone is scrambling for shares of the next Taser or Tilray.
Good luck to all involved!
As we witness LCTC trade to a new 52 week low, it certainly is disappointing to watch a profitable and successful company continue to not see any love.
There seems to still be a seller of shares that has been hanging around for well over a year now that continues to knock the stock down whenever we see any progress being made.
What I do know is that at some point this stock/company is going to make a move higher that will make all this waiting and watching worth it. I do not have the timeline or any idea of when this will happen but I am 110% confident that we see new all time highs in Lifeloc and a move that will produce extreme euphoria and make all of us holding very pleased to be investors.
I see Lifeloc as the biggest underdog in the sector and I enjoy rooting for the underdogs. Most of the community has written off Lifeloc as a potential candidate for the creation of the first marijuana breathalyzer.
Here's what we know in regards to progress being made:
SpinDx has demonstrated the ability to detect levels of THC down to 1 nanogram per milliliter under laboratory conditions. This includes resolving the psychoactive delta-9-THC from its inactive metabolites. Resolving the psychoactive levels from metabolites is an important step in establishing impairment. We believe this license agreement signifies the beginning of a relationship that will become material to the Company in the future. A prototype was built by Sandia under our Cooperative Research and Development Agreement and received in 2017, after which we commenced work on commercializing the device. We plan to continue and intensify these efforts.
We remain committed to completing development of a marijuana breathalyzer, utilizing the SpinDx technology.
The marijuana breathalyzer took a step closer to realization with the detection of delta-9-THC (the psychoactive agent) captured from a vapor sample. The ability of our technology to detect delta-9-THC down to a concentration of 5 nanograms per milliliter has been demonstrated in our laboratories. Detection is accomplished through the SpinDx technology, licensed exclusively by Lifeloc Technologies for drugs of abuse from Sandia National Laboratory. More work is needed to convert this technology into a simple-to-operate device suitable for roadside testing. The next step is human testing of the collection and detection mechanism.
With a current float of 362,192 that puts Lifeloc in the top 20 for lowest floats in the entire US market space as referenced here:
http://www.lowfloat.com/all_with_otcbb/
LCTC has the absolute lowest float of all marijuana/cannabis stocks and is profitable. Over 90%-95% of the entire sector is not profitable.
BLO/BLOZF sits at a market cap of approx $130 Million.
LCTC is right around $10 Million and traded at a 52 week low yesterday.